Mylan Claims Ranbaxy Sitting On Hypertension Drug Exclusivity
Mylan Pharmaceuticals Inc. told a Washington federal judge on Friday that it should be allowed to start marketing a generic version of its hypertension drug valsartan, alleging Ranbaxy Laboratories Ltd. has...To view the full article, register now.
Already a subscriber? Click here to view full article